You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
Title |
A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
|
---|---|
Published in |
Frontiers in Pharmacology, December 2023
|
DOI | 10.3389/fphar.2023.1213726 |
Pubmed ID | |
Authors |
Min You, Fentian Chen, Chao Yu, Yuanzhi Chen, Yue Wang, Xue Liu, Xueran Guo, Bing Zhou, Xin Wang, Boya Zhang, Mujin Fang, Tianying Zhang, Ping Yue, Yingbin Wang, Quan Yuan, Wenxin Luo |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#22,464,619
of 25,059,640 outputs
Outputs from Frontiers in Pharmacology
#12,145
of 19,203 outputs
Outputs of similar age
#128,629
of 161,519 outputs
Outputs of similar age from Frontiers in Pharmacology
#114
of 333 outputs
Altmetric has tracked 25,059,640 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,203 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,519 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 333 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.